This is an old revision of this page, as edited by ElBenevolente (talk | contribs) at 19:48, 16 December 2003 (added fda indications, deleted incorrect information that zyprexa was marketed as anti-parkonsonian). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 19:48, 16 December 2003 by ElBenevolente (talk | contribs) (added fda indications, deleted incorrect information that zyprexa was marketed as anti-parkonsonian)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Olanzapine (Zyprexa) is one of the atypical antipsychotic medications. Olanzapine has been FDA approved for treatment of schizophrenia and mania in bipolar disorder. The anti-psychiatry website Prozac Spotlight argues that a 1999 study demonstrated that the drug was ineffective in treatment of Parkinson's disease.
Side Effects
Common side effects include muscle-rigidity, muscle-stiffness, muscle-twitches, restlesness, sedation, and weight-gain. Olanzapine is reported to cause tardive dyskinesia and neurological malignant syndrome.
Olanzapine is manufactured by Eli Lilly (NYSE: LLY).